LifeStance Health Group (NASDAQ:LFST – Get Free Report) and Mangoceuticals (NASDAQ:MGRX – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.
Risk and Volatility
LifeStance Health Group has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.04, suggesting that its share price is 104% more volatile than the S&P 500.
Insider and Institutional Ownership
85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by company insiders. Comparatively, 16.0% of Mangoceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| LifeStance Health Group | 0 | 4 | 6 | 1 | 2.73 |
| Mangoceuticals | 1 | 0 | 0 | 0 | 1.00 |
LifeStance Health Group currently has a consensus target price of $12.38, indicating a potential downside of 2.79%. Given LifeStance Health Group’s stronger consensus rating and higher possible upside, analysts clearly believe LifeStance Health Group is more favorable than Mangoceuticals.
Profitability
This table compares LifeStance Health Group and Mangoceuticals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| LifeStance Health Group | 3.19% | 3.39% | 2.33% |
| Mangoceuticals | -4,794.60% | -96.39% | -89.60% |
Valuation and Earnings
This table compares LifeStance Health Group and Mangoceuticals”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| LifeStance Health Group | $1.42 billion | 3.47 | $9.66 million | $0.13 | 97.92 |
| Mangoceuticals | $460,000.00 | 19.27 | -$20.64 million | ($1.01) | -0.41 |
LifeStance Health Group has higher revenue and earnings than Mangoceuticals. Mangoceuticals is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.
Summary
LifeStance Health Group beats Mangoceuticals on 12 of the 15 factors compared between the two stocks.
About LifeStance Health Group
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
About Mangoceuticals
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
